TrialJournal of gastroenterology2019

Efficacy and safety of sofosbuvir-velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trial.

Tetsuo Takehara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.